[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100276392":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":11,"centralContacts":16,"locations":23,"responsibleParty":40,"collaborators":7,"id":42,"slug":43,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":44,"sex":49,"minAge":50,"maxAge":7,"enrollmentInfo":51,"targetDuration":54,"studyType":55,"phases":7,"briefSummary":56,"conditions":57,"keywords":60,"overallStatus":26,"whyStopped":7,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},{"fullName":5,"class":6},"University Hospital, Toulouse","OTHER",null,[9],{"type":6,"name":10,"description":7,"armGroupLabels":7,"otherNames":7},"no specific intervention",[12],{"name":13,"affiliation":14,"role":15},"Moulis Guillaume, MD PhD","University Hopsital Toulouse","PRINCIPAL_INVESTIGATOR",[17,20],{"name":13,"role":18,"phone":7,"phoneExt":7,"email":19},"CONTACT","moulis.g@chu-toulouse.fr",{"name":21,"role":18,"phone":7,"phoneExt":7,"email":22},"Johanne Germain, PhD","johanne.germain@inserm.fr",[24],{"facility":25,"status":26,"city":27,"state":7,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Service de Médecine Interne","RECRUITING","Toulouse","31000","France","FR",{"type":32,"coordinates":33},"Point",[34,35],1.44367,43.60426,{"lat":35,"lon":34},[38],{"name":39,"role":18,"phone":7,"phoneExt":7,"email":19},"Moulis Guillaume, MD, PhD",{"type":41,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100276392","french-registry-of-adult-patients-with-immune-thrombocytopenia-and-autoimmune-hemolytic-anemia-100276392",false,"NCT02877706","French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia","CARMEN","Inclusion Criteria:\n\n* adult patients (18+ year-old)\n* newly diagnosed for ITP\u002FAIHA or initiation of FOSFAMATINIB\n\nExclusion criteria:\n\n\\- opposition to data collection","ALL","18 Years",{"count":52,"type":53},1500,"ESTIMATED","15 Years","OBSERVATIONAL","CARMEN is a national, real-world clinical registry of all adult patients with incident diagnosis of Immune thrombocytopenia (ITP) or Autoimmune Hemolytic anemia (AIHA) patients in France. It is aimed at describing ITP and AIHA clinical features, assessing the real-world risk-benefit ratio of treatments and adherence to guidelines for ITP and AIHA management.",[58,59],"Immune Thrombocytopenia","Autoimmune Hemolytic Anemia",[61],"Registry","2025-12-23",{"date":64,"type":65},"2025-12-31","ACTUAL",{"date":67,"type":7},"2013-06",{"date":69,"type":53},"2029-12",{"name":5,"class":6},1]